We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

966:HKEXChina Taiping Insurance Holdings Co., Ltd. Analysis

Data as of 2026-03-14 - not real-time

HK$4.80

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock trades at HK$4.80, below the 20‑day (HK$4.90) and 50‑day (HK$4.88) simple moving averages and well under the 200‑day SMA of HK$6.13, indicating short‑term weakness. RSI sits at 46.9, essentially neutral, while the MACD histogram is negative and the signal line is bearish, reinforcing downside momentum. Volume is on a decreasing trend and price sits between a support of HK$4.54 and resistance of HK$5.33, leaving limited upside in the near term. Market sentiment is on the “Greed” side of the Fear & Greed Index (72.9), but the 30‑day volatility is high at 38.6%, suggesting price swings may be sharp.
Fundamental outlook: Revenue has collapsed by 55.7% year‑over‑year and margins are deeply negative (gross 11.5%, operating –310.9%, profit –102.9%). The company holds ample cash (HK$1.22 bn) against debt of HK$0.60 bn, yet operating cash flow remains negative and free cash flow is barely positive. The DCF‑derived fair value of HK$1.26 is far below the current price, implying overvaluation, while the price‑to‑book of 0.78 suggests the market is paying less than book value. With a debt‑to‑equity of 21.4 and a negative ROE, the balance sheet is strained, and no dividend is paid.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and decreasing volume
  • Proximity to near‑term support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential policy support for hydrogen sector
  • Large cash cushion offsetting debt
  • Valuation gap between DCF fair value and market price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Strategic positioning in emerging hydrogen fuel‑cell market
  • Low price‑to‑book indicating asset value
  • Long‑term tailwinds from renewable energy transition

Key Metrics & Analysis

Financial Health

Revenue Growth-55.70%
Profit Margin-102.94%
ROE-12.62%
ROA-5.92%
Debt/Equity21.43
P/B Ratio0.8
Op. Cash FlowHK$-256460000
Free Cash FlowHK$1.7M
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI46.9
SupportHK$4.54
ResistanceHK$5.33
MA 20HK$4.90
MA 50HK$4.88
MA 200HK$6.13
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueHK$1.26
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.10
Volatility38.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.